Publication | Open Access

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

OncologyMedicineClinical TrialsMetastatic Squamous NsclcFirst-line TreatmentPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyNovel TherapyPhase 3Health Sciences